IIM
LXEO icon

INTECH Investment Management’s Lexeo Therapeutics LXEO Stock Holding History

INTECH Investment Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Buy
17,817
+1,313
+8% +$7.1K ﹤0.01% 1979
2026
Q1 		$94.7K Buy
16,504
+2,316
+16% +$16.4K ﹤0.01% 1904
2025
Q4 		$141K Buy
14,188
+2,317
+20% +$21.1K ﹤0.01% 2089
2025
Q3 		$78.8K Sell
11,871
-1,811
-13% -$8.76K ﹤0.01% 2313
2025
Q2 		$55K Buy
13,682
+2,342
+21% +$7.7K ﹤0.01% 2411
2025
Q1 		$39.4K Sell
11,340
-225
-2% -$997 ﹤0.01% 2454
2024
Q4 		$76.1K Buy
+11,565
New +$91.1K ﹤0.01% 2267

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

INTECH Investment Management's LXEO Position: Q2 2026 in Review

INTECH Investment Management increased its Lexeo Therapeutics (LXEO) stake by 8% in Q2 2026, buying an estimated $7.1K and bringing the position to 17,817 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

INTECH Investment Management first reported a position in LXEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $141K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • INTECH Investment Management held 17,817 shares of Lexeo Therapeutics worth $82.9K as of Q2 2026.
  • INTECH Investment Management bought 1,313 Lexeo Therapeutics shares in Q2 2026, an estimated $7.1K.
  • Lexeo Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1979 holding.
  • INTECH Investment Management first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Lexeo Therapeutics position peaked at $141K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.